GI Surgery – Liver
M-A | Impact of perioperative steroid administration in patients undergoing elective liver resection
19 Jan, 2023 | 14:00h | UTC
ERAS Guidelines for perioperative care for liver surgery.
1 Nov, 2022 | 12:16h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Systematic Review | Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
5 Sep, 2022 | 14:13h | UTC
Meta-analysis of observational studies | In patients with hepatocellular carcinoma, intraoperative blood salvage during liver transplantation appears safe.
30 Aug, 2022 | 12:03h | UTC
Review | New concepts in the treatment of hepatocellular carcinoma.
24 Aug, 2022 | 13:56h | UTCNew concepts in the treatment of hepatocellular carcinoma – UEG Journal
Review | Acute liver failure management and liver transplantation.
15 Aug, 2022 | 11:41h | UTCCAQ Corner: Acute liver failure management and liver transplantation – Liver Transplantation
RCT | Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma.
5 Aug, 2022 | 13:50h | UTCLenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH) – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Adding TACE to Lenvatinib Boosts Survival in Advanced Liver Cancer — In China-based trial, overall survival in first-line improved by 6 months versus lenvatinib alone – MedPage Today (free registration required)
Case-Control Study | Survival benefit of living-donor liver transplant.
4 Aug, 2022 | 13:59h | UTCSurvival Benefit of Living-Donor Liver Transplant – JAMA Surgery
Commentaries:
Just How Low a Model for End-stage Liver Disease Score Benefits From Living-Donor Liver Transplant? – JAMA Surgery (free for a limited period)
Low MELD Score No Barrier to Long Survival After Living-Donor Transplant — End-stage liver disease patients with scores as low as 11 achieved survival of 13 years or beyond – MedPage Today (free registration required)
M-A | Repeat hepatic resection vs. percutaneous ablation for the treatment of recurrent hepatocellular carcinoma.
4 Aug, 2022 | 13:27h | UTC
Commentary on Twitter
Recurrent #HCC after resection: re-resect or ablate?
📰#systematicreviewRedo-Resection has:
– ⏫Morbidity 17% vs 3%
– ⏫ recurrence free survival (HR 0.79)
– ⚖️ overall survival (HR 0.93 (0.83-1.04))https://t.co/WWwsHNkNQ9#SoMe4Surgery #some4hpb@SEIQuirurgica @asgbi pic.twitter.com/h4apdpY7eh— BJS Open (@BjsOpen) May 6, 2022
M-A | Evidence on indications and techniques to increase the future liver remnant in children undergoing extended hepatectomy.
22 Jul, 2022 | 11:33h | UTC
Review | Liver biopsy in patients with alcohol-associated liver disease with acute-on-chronic liver failure.
22 Jul, 2022 | 11:28h | UTC
Cystic liver lesions: a pictorial review.
18 Jul, 2022 | 10:48h | UTCCystic liver lesions: a pictorial review – Insights into Imaging
Hypertensive disorders in pregnancy complicated by liver rupture or hematoma: a systematic review of 391 reported cases.
12 Jul, 2022 | 11:48h | UTC
Review: Portal vein thrombosis in cirrhosis.
15 Jun, 2022 | 10:38h | UTCPortal Vein Thrombosis in Cirrhosis – Journal of Clinical and Experimental Hepatology
Causes of liver cancer are changing around the world: some up, some down.
13 Jun, 2022 | 07:54h | UTCNews Release: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down – UC San Diego Health
Original Study: Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer – Cell Metabolism (link to abstract – $ for full-text)
ERAS Guidelines for perioperative care in elective abdominal and pelvic surgery at primary and secondary hospitals in low–middle-income countries.
1 Jun, 2022 | 12:08h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Update on perioperative management of patients undergoing surgery for liver cancer.
1 Jun, 2022 | 11:11h | UTC
The role of T-tubes and abdominal drains on short-term outcomes in liver transplantation – A systematic review of the literature and expert panel recommendations.
26 May, 2022 | 10:04h | UTC
Review: Management of refractory variceal bleed in cirrhosis.
20 May, 2022 | 10:36h | UTC
Systematic Review: Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
10 May, 2022 | 10:46h | UTC
Prevention and management of postoperative ileus: a review of current practice.
12 Apr, 2022 | 08:20h | UTCPrevention and Management of Postoperative Ileus: A Review of Current Practice – Cureus
M-A: Enhanced recovery care vs. traditional care in laparoscopic hepatectomy.
11 Apr, 2022 | 00:43h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)
Cohort Study: Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases.
6 Apr, 2022 | 10:23h | UTCCommentaries:
Living-Donor Liver Transplant Promising for CRC With Liver Mets – HealthDay
Commentary on Twitter
Study suggests living-donor liver transplant is a promising option for meticulously selected patients with unresectable colorectal cancer liver metastases. https://t.co/p6Jbzb73DL
— JAMA Surgery (@JAMASurgery) March 30, 2022
Review: Surgical risk assessment in patients with chronic liver diseases.
25 Mar, 2022 | 08:46h | UTC
Commentary on Twitter
Surgical Risk Assessment in Patients With Chronic Liver Diseases https://t.co/us01T2XsxE
— Journal of Clinical and Experimental Hepatology (@JCEH_Hepatology) March 23, 2022
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis.
21 Mar, 2022 | 10:01h | UTC